These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23468339)

  • 1. An automated system for monitoring and regulating the pH of bicarbonate buffers.
    Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
    AAPS PharmSciTech; 2013 Jun; 14(2):517-22. PubMed ID: 23468339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.
    Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
    Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo predictive dissolution: transport analysis of the CO2 , bicarbonate in vivo buffer system.
    Krieg BJ; Taghavi SM; Amidon GL; Amidon GE
    J Pharm Sci; 2014 Nov; 103(11):3473-3490. PubMed ID: 25212721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer.
    Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R
    Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
    Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
    Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.
    McNamara DP; Whitney KM; Goss SL
    Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems.
    Fadda HM; Merchant HA; Arafat BT; Basit AW
    Int J Pharm; 2009 Dec; 382(1-2):56-60. PubMed ID: 19666093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
    Shibata H; Yoshida H; Izutsu K; Goda Y
    J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is bicarbonate buffer suitable as a dissolution medium?
    Boni JE; Brickl RS; Dressman J
    J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of buffer species on biorelevant dissolution and precipitation assays - Comparison of phosphate and bicarbonate buffer.
    Krollik K; Lehmann A; Wagner C; Kaidas J; Kubas H; Weitschies W
    Eur J Pharm Biopharm; 2022 Feb; 171():90-101. PubMed ID: 34592364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
    Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M
    AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F; Shokrollahi H
    Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO
    Al-Gousous J; Sun KX; McNamara DP; Hens B; Salehi N; Langguth P; Bermejo M; Amidon GE; Amidon GL
    Mol Pharm; 2018 Nov; 15(11):5291-5301. PubMed ID: 30362350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility vs Dissolution in Physiological Bicarbonate Buffer.
    Claussen F; Al-Gousous J; Salehi N; Garcia MA; Amidon GL; Langguth P
    Pharm Res; 2024 May; 41(5):937-945. PubMed ID: 38698196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications.
    Al-Gousous J; Ruan H; Blechar JA; Sun KX; Salehi N; Langguth P; Job NM; Lipka E; Loebenberg R; Bermejo M; Amidon GE; Amidon GL
    Eur J Pharm Biopharm; 2019 Jun; 139():47-58. PubMed ID: 30872012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer.
    Yamamoto H; Sugano K
    Mol Pharm; 2024 Jun; 21(6):2854-2864. PubMed ID: 38718215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.
    Sheng JJ; McNamara DP; Amidon GL
    Mol Pharm; 2009; 6(1):29-39. PubMed ID: 19183104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
    Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
    Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.
    Okamoto N; Higashino M; Yamamoto H; Sugano K
    Pharm Res; 2024 May; 41(5):959-966. PubMed ID: 38653942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.